Ivy Leaf Extract Powder

Ivy Leaf Extract Powder is a concentrated botanical ingredient prepared from the leaves of Hedera helix L., a member of the Araliaceae family. Commercial dry extracts contain a characteristic triterpenoid saponin profile and are used in botanical supplement, nutraceutical, and formulation-development projects requiring a defined ivy leaf ingredient.

Available assay-defined grades include 5%, 10%, and 20% Hederacoside C by HPLC, with the 10% grade serving as the primary commercial specification. Separate ratio-based formats are also supplied for projects where botanical concentration rather than a fixed marker assay defines the ingredient.

SKU: BOT-BEX-0397 Categories: Botanical Extracts, Leaf & Herb Extracts Tags: Antioxidant Support, Dietary Supplements, Hederacoside C, Ivy, Polyphenols

Ingredient Profile & Common Uses

Ivy leaf extract is produced from the leaves of Hedera helix L. rather than from the stem, fruit, or whole aerial plant. It differs from simple ivy leaf powder because the botanical raw material undergoes extraction and concentration before conversion into a dry powder. The resulting ingredient contains triterpenoid saponins, with Hederacoside C providing the principal quantitative marker for many commercial extracts.

Commercial sourcing generally follows two specification systems. Assay-defined extracts provide a measured saponin marker level, while 10:1 and 20:1 extracts follow a separate ratio-based format. These specification systems describe different product attributes: a botanical extract ratio does not establish an equivalent active-marker percentage and should therefore be evaluated separately during supplier comparison and formulation development.

The concentrated powder is used where a defined Hedera helix leaf ingredient is preferred over untreated botanical material. Its saponin-rich composition can affect wetting and foam generation in aqueous processing, while dry formulations require appropriate premixing and blend-uniformity control. Dispersibility, sedimentation, sensory contribution, and compatibility with other botanical ingredients should be considered during development.

Application Areas

Capsules and Tablets

The extract can be incorporated into capsule and tablet products where formulators require a concentrated botanical ingredient with controlled marker input and consistent distribution through the finished blend.

Multi-Botanical Supplement Formulas

Ivy leaf extract can be combined with other herbal ingredients in complex formulations. Assay-defined grades provide a useful quantitative target for formulation control and raw-material comparison.

Oral Liquid Formulations

Dry extract powder may be evaluated for syrups and other liquid botanical systems. Wetting, dispersion, foaming, sedimentation, and flavor compatibility are important during bench and pilot-scale development.

Powdered Botanical Systems

Concentrated extract can be incorporated into premixes and other dry systems where particle distribution, premixing sequence, flow behavior, and uniformity at the selected inclusion level require evaluation.

Typical Specifications

Parameter	Specification
Product Name	Ivy Leaf Extract Powder
Botanical Name	Hedera helix L.
Common Name	Common Ivy / English Ivy
Botanical Family	Araliaceae
Plant Part	Leaf
Ingredient Type	Botanical Leaf Extract
Product Form	Dry Extract Powder
Available Standardized Grades	5% · 10% · 20% Hederacoside C
Primary Commercial Grade	10% Hederacoside C
Marker Compound	Hederacoside C
Analytical Method	HPLC
Ratio Extract Grades	10:1 · 20:1
Major Phytochemical Class	Triterpenoid Saponins

Marker Compounds & Standardization

Hederacoside C is a characteristic bidesmosidic triterpenoid saponin associated with Hedera helix leaf and serves as the principal quantitative marker for many concentrated ivy extracts. α-Hederin is another relevant ivy saponin, while hederagenin represents a triterpenoid aglycone associated with part of the plant’s saponin profile.

HPLC analysis provides a defined quantitative measurement of the selected marker and allows assay-based material to be distinguished from products specified only by botanical extraction ratio. This distinction is important when comparing raw materials because ratio values and marker percentages represent different analytical and commercial concepts.

Analyte definition should remain explicit in procurement documentation. Hederacoside C, total hederacosides, α-hederin, and hederagenin are different analytical targets and should not be treated as interchangeable assay names when reviewing specifications, COAs, supplier quotations, or formulation requirements.

Technical & Quality Considerations

Botanical identity should establish Hedera helix L. leaf as the source material. For assay-defined grades, quantitative HPLC testing provides the principal compositional control, while chromatographic identity or fingerprint evaluation can provide additional information about the broader saponin profile. This is particularly relevant because ivy extract is a multi-component botanical matrix rather than an isolated chemical compound.

Triterpenoid saponins can influence wetting and foam formation when the powder is introduced into aqueous systems, making addition sequence and mixing energy relevant during liquid processing. In dry applications, concentrated material may be incorporated at comparatively low inclusion levels, increasing the importance of premixing, powder distribution, and blend homogeneity.

Scale-up should focus on the finished dosage system rather than relying on assay alone. Capsule and tablet development should evaluate flow, blend uniformity, fill or compression behavior, and dose distribution. Liquid projects should assess wetting, dispersion, foam control, sedimentation, and sensory compatibility before commercial production.

Packaging & Commercial Supply

Essencefield supports product evaluation, formulation trials, commercial orders, and ongoing ingredient supply. Packaging, storage, and shipping arrangements are determined by product characteristics, order quantity, stability requirements, and destination-market needs.

Supply Item	General Information
Sample	Available upon request for formulation, testing, and supplier evaluation
Order Quantities	100 g · 1 kg · 5 kg · 25 kg · 100 kg · 500 kg · Bulk
Sample Lead Time	Typically 5–7 days after sample confirmation
Production Lead Time	Typically 15–30 days after order and specification confirmation
Packaging	Suitable protective inner packaging with bags, cartons, drums, or other appropriate outer packaging
Storage	Store in tightly sealed, suitable protective packaging in a cool, dry environment. Protect from moisture, heat, and direct sunlight. Specific storage conditions follow the approved product specification.
Documentation	COA · Product Specification · TDS · SDS · Applicable declarations (as applicable)

Final order quantities, lead times, packaging, documentation, and shipping arrangements are confirmed according to the selected product and commercial requirements.